Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse

[1]  B. Ghetti,et al.  In Vitro Release of Endogenous Dopamine from the Striatum of the Weaver Mutant Mouse , 1991, Journal of neurochemistry.

[2]  P. Kalivas,et al.  A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis , 1991, Journal of neurochemistry.

[3]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[4]  B. Ghetti,et al.  The dendritic dopamine projection of the substantia nigra: phenotypic denominator of weaver gene action in hetero- and homozygosity , 1989, Brain Research.

[5]  B. Ghetti,et al.  Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice , 1987, Brain Research.

[6]  A. Graybiel,et al.  The postnatal development of the dopamine-containing innervation of dorsal and ventral striatum: effects of the weaver gene , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  P. H. Andersen Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex , 1987, Journal of neurochemistry.

[8]  B. Ghetti,et al.  Selective loss of monoaminergic neurons in weaver mutant mice— an immunocytochemical study , 1987, Brain Research.

[9]  C. D. Stern,et al.  Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.

[10]  C. Marsden,et al.  Evidence that [3H]Dopamine Is Taken Up and Released from Nondopaminergic Nerve Terminals in the Rat Substantia Nigra In Vitro , 1985, Journal of neurochemistry.

[11]  A. Graybiel,et al.  Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum , 1984, Nature.

[12]  B. Ghetti,et al.  Dopamine deficiency in the weaver mutant mouse , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  P. Beart,et al.  Neurochemical Studies of the Mesolimbic Dopaminergic Pathway: Somatodendritic Mechanisms and GABAergic Neurones in the Rat Ventral Tegmentum , 1980, Journal of neurochemistry.

[14]  J. Meyerhoff,et al.  Release of endogenous norepinephrine and dopamine from rat brain regions in vitro. , 1978, Life sciences.

[15]  F. Hefti,et al.  SUBCELLULAR DISTRIBUTION OF DOPAMINE IN SUBSTANTIA NIGRA OF THE RAT BRAIN: EFFECTS OF γ‐BUTYROLACTONE AND DESTRUCTION OF NORADRENERGIC AFFERENTS SUGGEST FORMATION OF PARTICLES FROM DENDRITES 1 , 1978, Journal of neurochemistry.

[16]  B. Berger,et al.  Dopamine uptake in serotoninergic terminals in vitro: A valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures , 1978, Brain Research.

[17]  M. Starr GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum. , 1978, European journal of pharmacology.

[18]  P. Groves,et al.  Amphetamine-induced release of dopamine from the substantia nigra in vitro. , 1976, Life sciences.

[19]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[20]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.